Shikonin, a bioactive compound derived from traditional Chinese medicine with broad pharmacological effects, exerts some of its activity through the inhibition of PKM2 and reverses GEM resistance in pancreatic cancer cells [212]. The gene discussed is PKM; the disease is pancreatic neoplasm.